Aromatic Amino Acid Decarboxylase Inhibitors

DBCAT000471Therapeutic category

Compounds and drugs that block or inhibit the enzymatic action of AROMATIC AMINO ACID DECARBOXYLASES. Pharmaceutical agents in this category are used in conjunction with LEVODOPA in order to slow its metabolism. A DrugBank category of 1 drug. 1 of them is approved.

Also known as: Aromatic Amino Acid Decarboxylation Inhibitor · Aromatic L Amino Acid Decarboxylase Inihbitors · Aromatic-L-Amino-Acid Decarboxylase Inihbitors · Decarboxylase Inhibitors, Dihydroxyphenylalanine · Decarboxylase Inhibitors, DOPA
Drugs: Carbidopa

What you can answer from here — as of May 30, 2018

1DrugEach linked to its full drug card

Listed above

1Drug targetEvery drug–target pair in the class, with bond type

1,379Marketed productsAcross the regions we cover, with dosage forms and routes

5Routes of administrationHow the drugs in this class are given

Which targets do Aromatic Amino Acid Decarboxylase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account